Elucidating the tumor-suppressive mechanisms of GLS2 in the context of liver cancer, Suzuki et al., demonstrated that GLS2 can inhibit HCC in vivo by promoting ferroptosis. The gene discussed is GLS2; the disease is liver cancer.